Never inject into areas that are visibly bruised, inflamed, or showing signs of previous injection damage
Start slowly, use an appropriate concentration, choose a delivery vehicle that works with your skin barrier rather than against it, and be thoughtful about how you layer GHK-Cu with pH-sensitive actives like vitamin C and cell-turnover accelerators like retinol
Cardiovascular history Semaglutide has extensive cardiovascular outcome data, including the SELECT trial showing a 20% reduction in heart attacks and strokes in people with obesity
Very mild or subclinical hypothyroidism with no significant symptoms In cases of subclinical hypothyroidism, where the TSH is slightly elevated but free T4 remains normal, and the patient has minimal or no symptoms, GLP-1 therapy may be started if there is a strong clinical indication such as prediabetes, elevated waist circumference, or high cardiovascular risk
Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use, tablets, for oral use